STALLION
Stallion India Fluorochemicals Limited
Stallion India Fluorochemicals Limited (STALLION) financial statements and selected valuation metrics through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Industrial Gases
stallionfluorochemicals.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Stallion (Stallion India Fluorochemicals) debulks, blends, fills and distributes refrigerant and specialty gases to the air-conditioning and refrigeration industry across India, and is building its own R-32 refrigerant plant in Rajasthan.
Company snapshot
4thBy market cap
Ranked among 4 companies in Industrial Gases.
What we see
- ✓Debt-to-equity of 0.05x — the company is largely funded by its own money, not borrowed funds.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 85 Cr | 152 Cr | 110 Cr | 106 Cr | 105 Cr | 110 Cr | 121 Cr |
| Operating expenses (approx.) | 71 Cr | 133 Cr | 96 Cr | 90 Cr | 91 Cr | 94 Cr | 99 Cr |
| EBITDA | 14 Cr | 19 Cr | 14 Cr | 16 Cr | 13 Cr | 16 Cr | 22 Cr |
| OPM % | 16.8% | 12.3% | 12.9% | 14.8% | 12.7% | 14.9% | 18.1% |
| Other income | 0 Cr | 2 Cr | 0.07 Cr | 0.19 Cr | 0.23 Cr | 1 Cr | 3 Cr |
| Interest | 2 Cr | 2 Cr | 0.22 Cr | 0.23 Cr | 0.06 Cr | 0.38 Cr | 0.09 Cr |
| Depreciation | 0.30 Cr | 0.29 Cr | 0.29 Cr | 0.29 Cr | 0.30 Cr | 0.60 Cr | 0.39 Cr |
| Profit before tax | 12 Cr | 18 Cr | 14 Cr | 15 Cr | 13 Cr | 17 Cr | 25 Cr |
| Tax % | 20.4% | 27.3% | 25.2% | 25.1% | 15.8% | 34.4% | 25.1% |
| Net profit | 10 Cr | 13 Cr | 10 Cr | 11 Cr | 11 Cr | 11 Cr | 19 Cr |
| EPS (₹) | ₹1.59 | ₹1.76 | ₹1.31 | ₹1.42 | ₹1.40 | ₹1.33 | ₹1.60 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 377 Cr | 431 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 330 Cr | 373 Cr | Sign in free for the trailing twelve months |
| EBITDA | 48 Cr | 58 Cr | Sign in free for the trailing twelve months |
| OPM % | 12.6% | 13.4% | Sign in free for the trailing twelve months |
| Other income | 2 Cr | 3 Cr | Sign in free for the trailing twelve months |
| Interest | 6 Cr | 0.89 Cr | Sign in free for the trailing twelve months |
| Depreciation | 1 Cr | 1 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 42 Cr | 59 Cr | Sign in free for the trailing twelve months |
| Tax % | 23.8% | 25.7% | Sign in free for the trailing twelve months |
| Net profit | 32 Cr | 44 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹4.98 | ₹5.34 | Sign in free for the trailing twelve months |
| Dividend payout % | 0.0% | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 79 Cr | 116 Cr |
| Reserves | 222 Cr | 565 Cr |
| Borrowings | 2 Cr | 34 Cr |
| Other liabilities | 30 Cr | 22 Cr |
| Total liabilities | 334 Cr | 737 Cr |
| Fixed assets (net) | 17 Cr | 31 Cr |
| CWIP | 0.39 Cr | 35 Cr |
| Investments | 0 Cr | 0 Cr |
| Inventories | 101 Cr | 127 Cr |
| Trade receivables | 106 Cr | 78 Cr |
| Cash & bank | 59 Cr | 212 Cr |
| Other assets | 51 Cr | 255 Cr |
| Total assets | 334 Cr | 737 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operating activity | -13 Cr | 39 Cr |
| Cash from investing | -20 Cr | -253 Cr |
| Cash from financing | 76 Cr | 367 Cr |
| Net cash flow | 43 Cr | 154 Cr |
| Free cash flow (OCF − Capex) | -18 Cr | -10 Cr |
Ratios
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | 16.0% | 8.4% |
| ROE % | 10.7% | 6.4% |
| Debtor days | 102 | 66 |
| Inventory days | 125 | 125 |
| Days payable | 26 | 18 |
| Cash conversion cycle | 201 | 173 |
| OCF / EBITDA % | -28.1% | 68.0% |
| Debt / equity | 0.0081 | 0.05 |
| Current ratio | 9.45 | 11.85 |
| Net debt / EBITDA | -1.18 | -3.08 |